IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 401 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $214,000 | 0.0% | 3,536 | -1.1% | 0.01% | -16.7% |
| Q3 2019 | $214,000 | -6.1% | 3,576 | +1.0% | 0.01% | +9.1% |
| Q2 2019 | $228,000 | -2.1% | 3,541 | -18.0% | 0.01% | -35.3% |
| Q4 2018 | $233,000 | +4.5% | 4,316 | 0.0% | 0.02% | +41.7% |
| Q3 2018 | $223,000 | -98.3% | 4,316 | -98.4% | 0.01% | -97.3% |
| Q4 2016 | $13,101,000 | +30.5% | 273,900 | 0.0% | 0.45% | +36.8% |
| Q3 2016 | $10,036,000 | +57.3% | 273,900 | 0.0% | 0.33% | +41.2% |
| Q2 2016 | $6,379,000 | -33.3% | 273,900 | +16.1% | 0.23% | -33.0% |
| Q1 2016 | $9,558,000 | -27.2% | 236,000 | +11.3% | 0.35% | -23.0% |
| Q4 2015 | $13,129,000 | – | 212,000 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |